Pain News and Research

Latest Pain News and Research

Pitt professor receives NIH grant to test behavioral therapy for chronic pain in HIV patients

Living with HIV often means living with chronic pain, but behavioral therapy could offer an effective alternative to opioids.

21 Aug 2018

Christiana Care Health System successfully reduces opioid prescriptions

Before surgeon Emily Penman, M.D., begins a mastectomy or lumpectomy, her lightly sedated patient receives a nerve block, an injection of medicine to control pain after surgery.

21 Aug 2018

After-hours telemedicine can lead to fewer hospitalizations and more savings

When doctors could be reached via telemedicine to decide whether a patient in a skilled nursing facility (SNF) should be hospitalized, 29% of the patients evaluated avoided a hospital visit, saving $1.55 million over the course of a year, according to results reported in the current issue of The American Journal of Managed Care.

20 Aug 2018

Yale researchers identify racial disparities in prescribing opioids for chronic pain

Yale researchers have identified racial disparities in the treatment of patients who are prescribed opioids for chronic pain.

20 Aug 2018

Unique pain program helps surgical patients wean off opioids safely and effectively

A unique pain program is helping complex surgical patients wean off opioids safely and effectively, while offering alternative ways to cope with their pain and improve how they function.

20 Aug 2018

RDMD raises $3 million in seed funding to accelerate rare disease research, drug development

RDMD, a healthcare technology company dedicated to accelerating research for patients with rare diseases, today announced that it has raised $3 million in seed financing.

20 Aug 2018

New drug shows potential to prevent painful side effect of therapy

About 50,000 people in the U.S. are diagnosed annually with head, neck, nasal and oral cancers. Most are treated with radiation, and of those, 70-80 percent develop a painful and debilitating side effect called severe oral mucositis.

20 Aug 2018

Harbour Biomed and Kelun-Biotech collaborate to develop, commercialize anti-PD-L1 antibody

Harbour BioMed today announced it has entered into an exclusive strategic partnership with Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. to develop and commercialize A167, an anti-PD-L1 antibody in Phase 2 clinical development, worldwide outside of the Greater China region.

20 Aug 2018

New statewide program in North Dakota aims to stem opioid misuse

Preliminary estimates released by the U.S. Centers for Disease Control and Prevention show a nearly 7 percent increase in drug overdoses in 2017, with more than 72,000 deaths. Of the total deaths, almost 68 percent of them were tied to opioid use. A new statewide program in North Dakota called ONE Rx aims to stem opioid misuse by increasing awareness when patients first fill an opioid prescription.

17 Aug 2018

ACA's Medicaid expansion associated with increase in prescriptions for opioid use disorder treatment

Medicaid expansion under the Affordable Care Act (ACA) was associated with an overall increase in people filling prescriptions for buprenorphine with naloxone, which is a treatment for opioid use disorder, as well as an increase in people filling prescriptions for opioid pain relievers (OPRs) paid for by Medicaid in a data analysis from five states.

17 Aug 2018

FDA approves marketing of brainsway deep transcranial magnetic stimulation system for OCD

Today, the U.S. Food and Drug Administration permitted marketing of the Brainsway Deep Transcranial Magnetic Stimulation System for treatment of obsessive compulsive disorder (OCD).

17 Aug 2018

Hologic’s Cynosure division partners with Porter Instrument to distribute nitrous oxide and oxygen system

Hologic, Inc. today announced completion of an agreement between its Cynosure division and Porter Instrument, a business unit of Parker Hannifin Corporation, for distribution rights in the United States and Canada to Porter Instrument’s nitrous oxide and oxygen system, Nitronox.

From Hologic, Inc. 17 Aug 2018

CartiHeal and LSU Health successfully enroll first two patients in Agili-C IDE pivotal study

CartiHeal, developer of Agili-C, a proprietary implant for the treatment of joint surface lesions, and two LSU Health New Orleans orthopedic surgeons announced today the successful enrollment of the first two US patients in the Agili-C IDE pivotal study.

17 Aug 2018

OUHSC gets $20 million grant to advance research and patient care for Oklahomans

This week, the University of Oklahoma Health Sciences Center announced the nationally competitive renewal of a $20 million federal grant that will advance research and patient care for Oklahomans throughout the state.

17 Aug 2018

Federal advisory group publishes recommendations on prevention of acute, chronic pain

A University of Texas at Arlington professor led a federal advisory group that has published its recommendations on the prevention of acute and chronic pain to the Federal Research Pain Strategy, an interagency committee that oversees the government's long-term strategic plan to support pain research.

17 Aug 2018

Seeking solutions to treat scleroderma

It begins with cold hands. Not just put-on-some-gloves cold. Instead, the fingers overreact to cold by turning white or blue and may become numb or tingly.

17 Aug 2018

Podcast: KHN’s ‘What the Health?’ See you in court!

A federal district court judge in Texas has set Sept. 10 as the date for oral arguments in a case filed by Republican state attorneys general and governors from 20 states.

17 Aug 2018

FDA grants approval for first generic version of epinephrine auto-injector

The U.S. Food and Drug Administration today approved the first generic version of EpiPen and EpiPen Jr (epinephrine) auto-injector for the emergency treatment of allergic reactions, including those that are life-threatening (anaphylaxis), in adults and pediatric patients who weigh more than 33 pounds.

16 Aug 2018

Exercise reduces symptoms and fatigue in patients with chronic kidney disease

Just 12 weeks of aerobic and strength-based exercise reduces symptoms and levels of fatigue in patients with chronic kidney disease, a study in Leicester has found.

16 Aug 2018

FDA expands approval of Vertex' cystic fibrosis medicine to treat children aged 12 to <24 months

Vertex Pharmaceuticals Incorporated today announced the U.S. Food and Drug Administration approved KALYDECO® (ivacaftor) to include use in children with cystic fibrosis ages 12 to <24 months who have at least one mutation in their cystic fibrosis transmembrane conductance regulator gene that is responsive to KALYDECO based on clinical and/or in vitro assay data.

16 Aug 2018

Pain News and Research

Latest Pain News and Research

Pitt professor receives NIH grant to test behavioral therapy for chronic pain in HIV patients

Christiana Care Health System successfully reduces opioid prescriptions

After-hours telemedicine can lead to fewer hospitalizations and more savings

Yale researchers identify racial disparities in prescribing opioids for chronic pain

Unique pain program helps surgical patients wean off opioids safely and effectively

RDMD raises $3 million in seed funding to accelerate rare disease research, drug development

New drug shows potential to prevent painful side effect of therapy

Harbour Biomed and Kelun-Biotech collaborate to develop, commercialize anti-PD-L1 antibody

New statewide program in North Dakota aims to stem opioid misuse

ACA's Medicaid expansion associated with increase in prescriptions for opioid use disorder treatment

FDA approves marketing of brainsway deep transcranial magnetic stimulation system for OCD

Hologic’s Cynosure division partners with Porter Instrument to distribute nitrous oxide and oxygen system

CartiHeal and LSU Health successfully enroll first two patients in Agili-C IDE pivotal study

OUHSC gets $20 million grant to advance research and patient care for Oklahomans

Federal advisory group publishes recommendations on prevention of acute, chronic pain

Seeking solutions to treat scleroderma

Podcast: KHN’s ‘What the Health?’ See you in court!

FDA grants approval for first generic version of epinephrine auto-injector

Exercise reduces symptoms and fatigue in patients with chronic kidney disease

FDA expands approval of Vertex' cystic fibrosis medicine to treat children aged 12 to <24 months

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Pain News and Research

Latest Pain News and Research

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Newsletters you may be interested in